Legal Representation
Attorney
Moises A. Saltiel
USPTO Deadlines
Next Deadline
2021 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250819)
Due Date
August 19, 2031
Grace Period Ends
February 19, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 19, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 19, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 25, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 30, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 30, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 22, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 22, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 11, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business risk management; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business services, namely, formulation of best practices for biopharmaceutical companies; Pharmaceutical cost management services and drug utilization review services; Providing independent review of clinical trials for business purposes; Providing online business risk management service for use in project management; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
First Use Anywhere:
Jun 18, 2024
First Use in Commerce:
Jun 18, 2024
Class 042
Pharmaceutical product evaluation; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Laboratory research in the field of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Research on the subject of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
First Use Anywhere:
Jun 18, 2024
First Use in Commerce:
Jun 18, 2024
Additional Information
Design Mark
The mark consists of 2 open ended ovals with flat edges with a dot in the open end, laid horizontally and slightly displaced with a closed oval with flat edges laid vertically overlapping over the horizontal ovals over the words "PHEXKNO CONSULTING".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"consulting"